Skip to main content
. 2017 Dec 13;6(1):176–189. doi: 10.1002/iid3.211

Figure 5.

Figure 5

Dose and kinetic response of CXCL10, VEGF, IL‐1Ra and CXCL9 production by IFN‐activated CBMC. CBMC (106/ml) were treated with increasing doses of A) IFNα2 or B) IFNγ. CXCL10, VEGF and IL‐1Ra production was assayed at 6 h and 24 h by multiplex immunoassay (n = 6) and CXCL9 production was assayed by ELISA (n = 8). *p < 0.05, **p < 0.01, ***p < 0.001, paired t‐test (6 hour) or Dunn's multiple comparisons post test compared to media control (24 h).